732 related articles for article (PubMed ID: 32763152)
1. Universal test-and-treat in Zambian and South African correctional facilities: a multisite prospective cohort study.
Herce ME; Hoffmann CJ; Fielding K; Topp SM; Hausler H; Chimoyi L; Smith HJ; Chetty-Makkan CM; Mukora R; Tlali M; Olivier AJ; Muyoyeta M; Reid SE; Charalambous S
Lancet HIV; 2020 Dec; 7(12):e807-e816. PubMed ID: 32763152
[TBL] [Abstract][Full Text] [Related]
2. Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia.
Mukora R; Smith HJ; Herce ME; Chimoyi L; Hausler H; Fielding KL; Charalambous S; Hoffmann CJ
PLoS One; 2022; 17(8):e0272595. PubMed ID: 36006967
[TBL] [Abstract][Full Text] [Related]
3. "It's Not Like Taking Chocolates": Factors Influencing the Feasibility and Sustainability of Universal Test and Treat in Correctional Health Systems in Zambia and South Africa.
Topp SM; Chetty-Makkan CM; Smith HJ; Chimoyi L; Hoffmann CJ; Fielding K; Reid SE; Olivier AJ; Hausler H; Herce ME; Charalambous S
Glob Health Sci Pract; 2019 Jun; 7(2):189-202. PubMed ID: 31249019
[TBL] [Abstract][Full Text] [Related]
4. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
[TBL] [Abstract][Full Text] [Related]
5. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda.
Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C
Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488
[TBL] [Abstract][Full Text] [Related]
6. Effects of implementing universal and rapid HIV treatment on initiation of antiretroviral therapy and retention in care in Zambia: a natural experiment using regression discontinuity.
Mody A; Sikazwe I; Namwase AS; Wa Mwanza M; Savory T; Mwila A; Mulenga L; Herce ME; Mweebo K; Somwe P; Eshun-Wilson I; Sikombe K; Beres LK; Pry J; Holmes CB; Bolton-Moore C; Geng EH
Lancet HIV; 2021 Dec; 8(12):e755-e765. PubMed ID: 34656208
[TBL] [Abstract][Full Text] [Related]
7. Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study.
Dorward J; Sookrajh Y; Khubone T; van der Molen J; Govender R; Phakathi S; Lewis L; Bottomley C; Maraj M; Lessells RJ; Naidoo K; Butler CC; Van Heerden R; Garrett N
Lancet HIV; 2023 May; 10(5):e284-e294. PubMed ID: 37001536
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
[TBL] [Abstract][Full Text] [Related]
9. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
[TBL] [Abstract][Full Text] [Related]
10. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
[TBL] [Abstract][Full Text] [Related]
11. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
[TBL] [Abstract][Full Text] [Related]
12. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
[TBL] [Abstract][Full Text] [Related]
13. The cascade of HIV care among key populations in Indonesia: a prospective cohort study.
Januraga PP; Reekie J; Mulyani T; Lestari BW; Iskandar S; Wisaksana R; Kusmayanti NA; Subronto YW; Widyanthini DN; Wirawan DN; Wongso LV; Sudewo AG; Sukmaningrum E; Nisa T; Prabowo BR; Law M; Cooper DA; Kaldor JM
Lancet HIV; 2018 Oct; 5(10):e560-e568. PubMed ID: 30143455
[TBL] [Abstract][Full Text] [Related]
14. Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya.
Kimanga DO; Oramisi VA; Hassan AS; Mugambi MK; Miruka FO; Muthoka KJ; Odhiambo JO; Yegon PK; Omoro GO; Mbaire C; Masamaro KM; Njogo SM; Barker JL; Ngugi CN
PLoS One; 2022; 17(11):e0277675. PubMed ID: 36413522
[TBL] [Abstract][Full Text] [Related]
15. Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
Floyd S; Ayles H; Schaap A; Shanaube K; MacLeod D; Phiri M; Griffith S; Bock P; Beyers N; Fidler S; Hayes R;
PLoS One; 2018; 13(8):e0197904. PubMed ID: 30096139
[TBL] [Abstract][Full Text] [Related]
16. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
[TBL] [Abstract][Full Text] [Related]
17. Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial.
Limbada M; Macleod D; Situmbeko V; Muhau E; Shibwela O; Chiti B; Floyd S; Schaap AJ; Hayes R; Fidler S; Ayles H;
Lancet HIV; 2022 Jan; 9(1):e13-e23. PubMed ID: 34843674
[TBL] [Abstract][Full Text] [Related]
18. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
19. Initial implementation of HIV pre-exposure prophylaxis for people who are incarcerated in Zambia: a cross-sectional observational study.
Lindsay B; Nyirongo N; Mwango L; Toeque MG; Masumba C; Litongola JP; Sikanyika J; Kabombo H; Moyo M; Siachibila S; Mudenda J; Tembo K; Olowski P; Olufunso A; Muchinda E; Musonda B; Okuku J; Mwila A; Moonga CN; Herce ME; Claassen CW
Lancet HIV; 2023 Jan; 10(1):e24-e32. PubMed ID: 36243018
[TBL] [Abstract][Full Text] [Related]
20. HIV incidence, pregnancy, and implementation outcomes from the Sakh'umndeni safer conception project in South Africa: a prospective cohort study.
Schwartz SR; Bassett J; Mutunga L; Yende N; Mudavanhu M; Phofa R; Sanne I; Van Rie A
Lancet HIV; 2019 Jul; 6(7):e438-e446. PubMed ID: 31160268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
